Cargando…
c-myc oncogene product expression and prognosis in operable breast cancer.
The 62 kDa protein product of the c-myc oncogene (p62 c-myc) is thought to be involved in the control of normal cellular proliferation and differentiation. We have measured oncoprotein levels using a flow cytometric assay in 141 operable breast cancers and have correlated levels with prognostic vari...
Autores principales: | Locker, A. P., Dowle, C. S., Ellis, I. O., Elston, C. W., Blamey, R. W., Sikora, K., Evan, G., Robins, R. A. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1989
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2247286/ https://www.ncbi.nlm.nih.gov/pubmed/2679850 |
Ejemplares similares
-
Invasive lobular carcinomas of the breast--the prognosis of histopathological subtypes.
por: du Toit, R. S., et al.
Publicado: (1989) -
Tumour aneuploidy, prognostic parameters and survival in primary breast cancer.
por: Owainati, A. A., et al.
Publicado: (1987) -
Evaluation of immunoreactivity with monoclonal antibody NCRC 11 in breast carcinoma.
por: Ellis, I. O., et al.
Publicado: (1987) -
Detection of the c-myc oncogene product in testicular cancer.
por: Sikora, K., et al.
Publicado: (1985) -
Detection of the c-myc oncogene product in colonic polyps and carcinomas.
por: Stewart, J., et al.
Publicado: (1986)